NeonatalNCT07773896
The Effect of Infant Massage Applied at Different Durations on Comfort and Physiological Stability in Late Preterm Infants Receiving nCPAP
A study testing 1. İntervention group and 2. İntervention group in people with Neonatal and Preterm, run by Tarsus University at 1 site in Turkey (Türkiye).
Trial summary
Aim: The aim of this study is to investigate the effects of massage administered for varying durations on comfort levels and physiological stability in late-preterm newborns receiving nCPAP. Read more about this study
- Who is it for?
- Ages 1 day to 1 monthHealthy volunteers can take part
- What is being tested?
- 1. İntervention group and 2. İntervention group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Sep 2026to 1 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 day to 1 month
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Newborns must:
- Be between 34⁰/₇ and 36⁶/₇ weeks of gestation,
- Be receiving nCPAP support,
- Be hemodynamically stable,
- Have started enteral feeding,
- Have no congenital anomalies,
- Their parents must voluntarily agree to participate in the study and provide written informed consent.
Who cannot join
- Newborns who:
- Are receiving invasive mechanical ventilation,
- Have undergone a surgical procedure,
- Have a neurological disorder or a serious congenital anomaly,
- Are receiving sedatives or neuromuscular blocking agents,
- Whose clinical condition is not suitable for massage,
- Who have a dermatological condition that could compromise skin integrity or a skin lesion that could interfere with massage,
- Who have medical device-related pressure injuries caused by nCPAP.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Fadime Kısa, BsC contact
Turkey (Türkiye)1 site
Tarsus University
Mersin, 33400
Duygu SÖNMEZ DÜZKAYA, PhD, ++903246000033 ext. 2200, duygusduzkaya@tarsus.edu.tr
About this study
Aim: The aim of this study is to investigate the effects of massage administered for varying durations on comfort levels and physiological stability in late-preterm newborns receiving nCPAP. Method: The study will be conducted between Agust 2026 and June 2027 at the Neonatal Intensive Care Unit of Tarsus State Hospital with late preterm infants who will receive nCPAP therapy. Late preterm infants scheduled to receive nCPAP therapy (a total of 90 infants) will be divided into three groups (intervention group 1: 30; intervention group 2: 30; control group: 30). The pre-procedure comfort levels of all newborns will be assessed using the COMFORTneo Scale. In addition, the infants' heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. In addition to standard clinical procedures, newborns in the first intervention group will receive massage for 5 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the second intervention group will receive massage for 10 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the control group will not receive any additional intervention; only the clinic's routine care protocols will be followed.
After each massage session is completed, the newborns' comfort levels will be reassessed using the COMFORTneo Scale; heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. This procedure will be repeated for each session throughout the 3-day intervention period, and all measurements will be recorded on the follow-up form.
Read the detailed description
The study is planned to be conducted between August and June at the Neonatal Intensive Care Unit (NICU) of Tarsus State Hospital. The NICU at Tarsus State Hospital is a tertiary-care center that provides advanced neonatal care services and monitors premature and high-risk newborns. The care and treatment of preterm newborns receiving noninvasive mechanical ventilation support in the unit are provided through a multidisciplinary team approach. Since the unit where the study will be conducted monitors late-preterm newborns receiving nCPAP support, it provides a suitable clinical environment for the study.
Variables:
Dependent variables: Comfort level (COMFORTneo Scale score), Heart rate (HR), Respiratory rate, Oxygen saturation (SpO₂), Body temperature Independent variables: Massage duration (5 minutes / 10 minutes / control), Frequency of application (twice daily for 3 days) Control variables: Gestational age (34⁰/₇-36⁶/₇), Birth weight, Sex, Nutritional status Study Implementation and Data Collection The necessary ethical committee and institutional approvals will be obtained before the study begins. The necessary plans regarding the study process will be made at the Neonatal Intensive Care Unit of Tarsus State Hospital, where the study will be conducted; team coordination, the implementation schedule, and the data collection process will be determined in advance. The implementation steps of the study are listed below.
Pilot Study: A pilot study will be conducted prior to the main study to assess the feasibility of the data collection forms and the appropriateness of the research process. Newborns included in the pilot study will not be included in the research sample.
Consent Process: The parents of late-preterm newborns who meet the inclusion criteria for the study will be informed about the purpose of the study, the implementation process, the data collection stages, and potential situations that may arise during the massage intervention (such as desaturation, bradycardia, or tachycardia; in the event that signs of physiological instability are observed, the intervention will be immediately discontinued and the necessary clinical intervention will be provided). Written informed consent will be obtained from parents who agree to participate in the study. It will be clearly stated that parents may withdraw their consent to participate in the study at any time without providing a reason and without affecting their infant's care.
Recording of Demographic Information: The sociodemographic and clinical characteristics of the newborns included in the study-including gestational age, birth weight, sex, mode of delivery, Apgar score, nCPAP usage status, and clinical characteristics-will be recorded by the researcher using the Newborn Demographic Information Form. Pre-Test Measurements: The pre-procedure comfort levels of all newborns included in the study will be assessed using the COMFORTneo Scale by a trained nurse-who is different from the researcher administering the massage-in order to minimize observer bias. The same nurse will read the newborns' heart rate, respiratory rate, oxygen saturation, and body temperature from the monitor and record them on the Pre- and Post-Intervention Physiological Parameters and Comfort Monitoring Form.
Randomization: Newborns who have completed the baseline measurements will be randomly assigned in equal numbers to three groups-the first intervention group, the second intervention group, and the control group-using a computer-generated randomization list. It is planned to include 30 newborns in each group, with a total of 90 newborns targeted for inclusion in the study.
Group Interventions: Newborns in the intervention groups will receive massage based on the tactile/kinesthetic stimulation approach developed by Field et al. (1986). The massage sessions will be conducted by the researcher.
The massage sessions were scheduled in accordance with the standard feeding schedule of the neonatal intensive care unit; massages are planned to be performed twice daily-at 10:00 a.m. and 4:00 p.m.-at least one hour after feeding. Prior to each session, the newborn's hemodynamic stability will be assessed; during the session, heart rate, respiratory rate, and oxygen saturation levels will be monitored (dos Anjos et al., 2021). If desaturation, bradycardia, tachycardia, or signs of clinical instability are observed during the session, the massage will be stopped immediately and the clinical team will be notified.
- First intervention group: In addition to routine clinical care, newborns in this group will receive a 5-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol."
- Second intervention group: In addition to routine clinical care, newborns in this group will receive a 10-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol."
- Control group: No additional interventions will be administered to the newborns in this group; only the clinic's routine care protocols will be followed. - Routine clinical care includes: maintaining nCPAP support; carrying out treatment and monitoring procedures in accordance with physicians' orders; administering enteral nutrition; ensuring proper positioning; providing oral and skin care; monitoring vital signs; implementing infection control measures; and providing developmental care.
Recording Final Measurements: After the completion of each massage session, the same nurse who performed the initial measurements will reassess the newborns' comfort levels using the COMFORTneo Scale (Appendix 2); heart rate, respiratory rate, oxygen saturation, and body temperature values will be recorded. This procedure will be repeated for each session throughout the 3-day intervention period, and all measurements will be recorded on the follow-up form provided in Appendix 3.
Massage Protocol The massage will be performed in accordance with the Field massage technique, which is widely used in the literature for preterm newborns (Field et al., 1986; Diego and Field, 2009). During the session, the newborn's tolerance level will be taken into account, and the massage will be adjusted based on the newborn's behavioral cues.
Natural cold-pressed olive oil will be used during the massage to lubricate the skin and reduce friction-related skin irritation (Bal Yılmaz, 2019; Jabraeile et al., 2016). Oil will not be applied to the face. The sessions will be conducted in an environment where the incubator temperature is maintained at 32-34°C to preserve the newborn's thermal stability. Rhythmic, moderate-pressure tactile stimulation will be applied to the face, chest, upper extremities, lower extremities, and back of the newborns in both supine and prone positions, in accordance with the tactile/kinesthetic stimulation approach developed by Field and colleagues.
The massage will utilize effleurage, petrissage, and friction techniques involving light pressure. Throughout the procedure, the newborns' heart rate, respiratory rate, and oxygen saturation levels will be monitored. If desaturation, bradycardia, tachycardia, or signs of physiological stress are observed during the procedure, the session will be terminated (Field, 2014; dos Anjos et al., 2021).
Routine clinical care: Routine clinical care includes the continuation of nCPAP support; the implementation of treatment and monitoring procedures in accordance with physicians' orders; nutritional care; repositioning; oral and skin care; monitoring of vital signs; infection control measures; and developmental care. No massage therapy will be provided to the control group as part of this study.
- Being tested
- 1. İntervention group, 2. İntervention group
- Keywords
- nCPAP, massage
- Medical subject headings
- Premature Birth
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
1. İntervention groupOther
In addition to routine clinical care, newborns in this group will receive a 5-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol.
2. İntervention groupOther
In addition to routine clinical care, the newborns in this group will receive a 10-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol.
| Study group | Role | What they receive |
|---|---|---|
| 5-minute massage session group | Experimental | In addition to routine clinical care, newborns in this group will receive a 5-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol." Receives: Other: 1. İntervention group |
| 10-minute massage session group | Experimental | In addition to routine clinical care, newborns in this group will receive a 10-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol. Receives: Other: 2. İntervention group |
| Control Group | No intervention | No additional interventions will be administered to the newborns in this group; only the clinic's routine care protocols will be followed. |
What is being measured
The primary outcome is the main question the study is designed to answer.
NEWBORN INFORMATIONAL FORM
The form, prepared by the researcher in accordance with the literature, will consist of questions regarding the newborn's gestational age, birth weight, sex, mode of delivery, Apgar score, nCPAP usage status, and clinical characteristics (Karnati, 2020; Kahraman et al., 2020). The form is planned to include questions designed to assess the newborn's sociodemographic and clinical characteristics.
Measured: 1 day
COMFORTNEO SCALE
The COMFORTneo Scale was developed by Van Dijk et al. (2009) to assess pain, stress, and comfort levels in preterm infants. The scale consists of a total of six parameters: level of alertness, calmness/agitation, respiratory response, crying, body movements, and facial tension. Each item is scored on a scale of 1 to 5, and the total possible score ranges from 6 to 30. A higher score on the scale indicates increased stress and distress in the newborn, while lower scores indicate a higher level of comfort.
Measured: Day 1, Day 2, Day 3
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2026
- Study start25 Sep 2026 (estimated)
- Primary completion10 Mar 2027 (estimated)
- Study completion1 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for NeonatalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tarsus University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Duygu Sonmez Duzkaya, Tarsus University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07773896
- Sponsor's protocol ID
- 2026/09
- Status last verified
- Aug 2026
- First submitted
- 6 Aug 2026
- Last updated
- 19 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
https://doi.org/10.3389/fpsyg.2019.02298 McCarty, D. B., Zukowsky, K., & Hockenberry, M. (2023). Developmental care interventions in neonatal intensive care units. Journal of Pediatric Nursing, 69, 45-52.
Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol. 2012 Dec;39(4):769-83. doi: 10.1016/j.clp.2012.09.009.
PubMed 23164177Guimarães, H., Rocha, G., & Pissarra, S. (2019). Nasal CPAP complications in preterm infants. Journal of Neonatal Nursing, 25(3), 125-131.
Field T. Pediatric Massage Therapy Research: A Narrative Review. Children (Basel). 2019 Jun 6;6(6):78. doi: 10.3390/children6060078.
PubMed 31174382De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD002977. doi: 10.1002/14651858.CD002977.pub2.
PubMed 18254011Coughlin M, Gibbins S, Hoath S. Core measures for developmentally supportive care in neonatal intensive care units: theory, precedence and practice. J Adv Nurs. 2009 Oct;65(10):2239-48. doi: 10.1111/j.1365-2648.2009.05052.x.
PubMed 19686402Cheong, J. L. Y., Spittle, A. J., Burnett, A. C., Anderson, P. J., & Doyle, L. W. (2020). Preterm birth and neurodevelopmental outcomes. Clinics in Perinatology, 47(1), 1-14.
Behnke, J., Lemyre, B., & Laughon, M. (2019). Non-invasive respiratory support in neonates. Current Opinion in Pediatrics, 31(2), 220-226.
Acolet D, Modi N, Giannakoulopoulos X, Bond C, Weg W, Clow A, Glover V. Changes in plasma cortisol and catecholamine concentrations in response to massage in preterm infants. Arch Dis Child. 1993 Jan;68(1 Spec No):29-31. doi: 10.1136/adc.68.1_spec_no.29.
PubMed 8439193Asadollahi, M., Eskandari, N., & Hasanpour, M. (2016). Effects of developmental care on preterm infant outcomes: A review study. International Journal of Pediatrics, 4(10), 3711-3720.
Arham M, Wroblewska-Seniuk K. Short- and Long-Term Consequences of Late-Preterm and Early-Term Birth. Children (Basel). 2025 Jul 9;12(7):907. doi: 10.3390/children12070907.
PubMed 40723099
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Infant Massage Applied at Different Durations on Comfort and Physiological Stability in Late Preterm Infants Receiving nCPAP
- ClinicalTrials.gov ID
- NCT07773896
- Acronym / sponsor ID
- 2026/09
- Keywords
- nCPAP, massage
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Tarsus UniversityUniversity, hospital or other
- Study start
- 25 Sep 2026 (estimated)
- Primary completion
- 10 Mar 2027 (estimated)
- Study completion
- 1 Jun 2027 (estimated)
- First posted
- 19 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: The aim of this study is to investigate the effects of massage administered for varying durations on comfort levels and physiological stability in late-preterm newborns receiving nCPAP. Method: The study will be conducted between Agust 2026 and June 2027 at the Neonatal Intensive Care Unit of Tarsus State Hospital with late preterm infants who will receive nCPAP therapy. Late preterm infants scheduled to receive nCPAP therapy (a total of 90 infants) will be divided into three groups (intervention group 1: 30; intervention group 2: 30; control group: 30). The pre-procedure comfort levels of all newborns will be assessed using the COMFORTneo Scale. In addition, the infants' heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. In addition to standard clinical procedures, newborns in the first intervention group will receive massage for 5 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the second intervention group will receive massage for 10 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the control group will not receive any additional intervention; only the clinic's routine care protocols will be followed.
After each massage session is completed, the newborns' comfort levels will be reassessed using the COMFORTneo Scale; heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. This procedure will be repeated for each session throughout the 3-day intervention period, and all measurements will be recorded on the follow-up form.
Detailed description
The study is planned to be conducted between August and June at the Neonatal Intensive Care Unit (NICU) of Tarsus State Hospital. The NICU at Tarsus State Hospital is a tertiary-care center that provides advanced neonatal care services and monitors premature and high-risk newborns. The care and treatment of preterm newborns receiving noninvasive mechanical ventilation support in the unit are provided through a multidisciplinary team approach. Since the unit where the study will be conducted monitors late-preterm newborns receiving nCPAP support, it provides a suitable clinical environment for the study.
Variables:
Dependent variables: Comfort level (COMFORTneo Scale score), Heart rate (HR), Respiratory rate, Oxygen saturation (SpO₂), Body temperature Independent variables: Massage duration (5 minutes / 10 minutes / control), Frequency of application (twice daily for 3 days) Control variables: Gestational age (34⁰/₇-36⁶/₇), Birth weight, Sex, Nutritional status Study Implementation and Data Collection The necessary ethical committee and institutional approvals will be obtained before the study begins. The necessary plans regarding the study process will be made at the Neonatal Intensive Care Unit of Tarsus State Hospital, where the study will be conducted; team coordination, the implementation schedule, and the data collection process will be determined in advance. The implementation steps of the study are listed below.
Pilot Study: A pilot study will be conducted prior to the main study to assess the feasibility of the data collection forms and the appropriateness of the research process. Newborns included in the pilot study will not be included in the research sample.
Consent Process: The parents of late-preterm newborns who meet the inclusion criteria for the study will be informed about the purpose of the study, the implementation process, the data collection stages, and potential situations that may arise during the massage intervention (such as desaturation, bradycardia, or tachycardia; in the event that signs of physiological instability are observed, the intervention will be immediately discontinued and the necessary clinical intervention will be provided). Written informed consent will be obtained from parents who agree to participate in the study. It will be clearly stated that parents may withdraw their consent to participate in the study at any time without providing a reason and without affecting their infant's care.
Recording of Demographic Information: The sociodemographic and clinical characteristics of the newborns included in the study-including gestational age, birth weight, sex, mode of delivery, Apgar score, nCPAP usage status, and clinical characteristics-will be recorded by the researcher using the Newborn Demographic Information Form. Pre-Test Measurements: The pre-procedure comfort levels of all newborns included in the study will be assessed using the COMFORTneo Scale by a trained nurse-who is different from the researcher administering the massage-in order to minimize observer bias. The same nurse will read the newborns' heart rate, respiratory rate, oxygen saturation, and body temperature from the monitor and record them on the Pre- and Post-Intervention Physiological Parameters and Comfort Monitoring Form.
Randomization: Newborns who have completed the baseline measurements will be randomly assigned in equal numbers to three groups-the first intervention group, the second intervention group, and the control group-using a computer-generated randomization list. It is planned to include 30 newborns in each group, with a total of 90 newborns targeted for inclusion in the study.
Group Interventions: Newborns in the intervention groups will receive massage based on the tactile/kinesthetic stimulation approach developed by Field et al. (1986). The massage sessions will be conducted by the researcher.
The massage sessions were scheduled in accordance with the standard feeding schedule of the neonatal intensive care unit; massages are planned to be performed twice daily-at 10:00 a.m. and 4:00 p.m.-at least one hour after feeding. Prior to each session, the newborn's hemodynamic stability will be assessed; during the session, heart rate, respiratory rate, and oxygen saturation levels will be monitored (dos Anjos et al., 2021). If desaturation, bradycardia, tachycardia, or signs of clinical instability are observed during the session, the massage will be stopped immediately and the clinical team will be notified.
- First intervention group: In addition to routine clinical care, newborns in this group will receive a 5-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol."
- Second intervention group: In addition to routine clinical care, newborns in this group will receive a 10-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol."
- Control group: No additional interventions will be administered to the newborns in this group; only the clinic's routine care protocols will be followed. - Routine clinical care includes: maintaining nCPAP support; carrying out treatment and monitoring procedures in accordance with physicians' orders; administering enteral nutrition; ensuring proper positioning; providing oral and skin care; monitoring vital signs; implementing infection control measures; and providing developmental care.
Recording Final Measurements: After the completion of each massage session, the same nurse who performed the initial measurements will reassess the newborns' comfort levels using the COMFORTneo Scale (Appendix 2); heart rate, respiratory rate, oxygen saturation, and body temperature values will be recorded. This procedure will be repeated for each session throughout the 3-day intervention period, and all measurements will be recorded on the follow-up form provided in Appendix 3.
Massage Protocol The massage will be performed in accordance with the Field massage technique, which is widely used in the literature for preterm newborns (Field et al., 1986; Diego and Field, 2009). During the session, the newborn's tolerance level will be taken into account, and the massage will be adjusted based on the newborn's behavioral cues.
Natural cold-pressed olive oil will be used during the massage to lubricate the skin and reduce friction-related skin irritation (Bal Yılmaz, 2019; Jabraeile et al., 2016). Oil will not be applied to the face. The sessions will be conducted in an environment where the incubator temperature is maintained at 32-34°C to preserve the newborn's thermal stability. Rhythmic, moderate-pressure tactile stimulation will be applied to the face, chest, upper extremities, lower extremities, and back of the newborns in both supine and prone positions, in accordance with the tactile/kinesthetic stimulation approach developed by Field and colleagues.
The massage will utilize effleurage, petrissage, and friction techniques involving light pressure. Throughout the procedure, the newborns' heart rate, respiratory rate, and oxygen saturation levels will be monitored. If desaturation, bradycardia, tachycardia, or signs of physiological stress are observed during the procedure, the session will be terminated (Field, 2014; dos Anjos et al., 2021).
Routine clinical care: Routine clinical care includes the continuation of nCPAP support; the implementation of treatment and monitoring procedures in accordance with physicians' orders; nutritional care; repositioning; oral and skin care; monitoring of vital signs; infection control measures; and developmental care. No massage therapy will be provided to the control group as part of this study.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| 5-minute massage session group | Experimental | Other: 1. İntervention groupIn addition to routine clinical care, newborns in this group will receive a 5-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol." |
| 10-minute massage session group | Experimental | Other: 2. İntervention groupIn addition to routine clinical care, newborns in this group will receive a 10-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol. |
| Control Group | No intervention | –No additional interventions will be administered to the newborns in this group; only the clinic's routine care protocols will be followed. |
Who may qualify
- Ages
- 1 day to 1 month
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Newborns must:
- Be between 34⁰/₇ and 36⁶/₇ weeks of gestation,
- Be receiving nCPAP support,
- Be hemodynamically stable,
- Have started enteral feeding,
Key exclusion criteria (8 listed)
- Newborns who:
- Are receiving invasive mechanical ventilation,
- Have undergone a surgical procedure,
- Have a neurological disorder or a serious congenital anomaly,
- Are receiving sedatives or neuromuscular blocking agents,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 1. İntervention groupIn addition to routine clinical care, newborns in this group will receive a 5-minute massage twice a day for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol. | Other | 5-minute massage session group |
| 2. İntervention groupIn addition to routine clinical care, the newborns in this group will receive a 10-minute massage twice daily for 3 days. The massage will be performed in accordance with the "Massage Administration Protocol. | Other | 10-minute massage session group |
Primary outcome
NEWBORN INFORMATIONAL FORM
Time frame: 1 day
The form, prepared by the researcher in accordance with the literature, will consist of questions regarding the newborn's gestational age, birth weight, sex, mode of delivery, Apgar score, nCPAP usage status, and clinical characteristics (Karnati, 2020; Kahraman et al., 2020). The form is planned to include questions designed to assess the newborn's sociodemographic and clinical characteristics.
COMFORTNEO SCALE
Time frame: Day 1, Day 2, Day 3
The COMFORTneo Scale was developed by Van Dijk et al. (2009) to assess pain, stress, and comfort levels in preterm infants. The scale consists of a total of six parameters: level of alertness, calmness/agitation, respiratory response, crying, body movements, and facial tension. Each item is scored on a scale of 1 to 5, and the total possible score ranges from 6 to 30. A higher score on the scale indicates increased stress and distress in the newborn, while lower scores indicate a higher level of comfort.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2026.
- Backgroundhttps://doi.org/10.3389/fpsyg.2019.02298 McCarty, D. B., Zukowsky, K., & Hockenberry, M. (2023). Developmental care interventions in neonatal intensive care units. Journal of Pediatric Nursing, 69, 45-52.
- Background: PubMed 23164177Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol. 2012 Dec;39(4):769-83. doi: 10.1016/j.clp.2012.09.009.
- BackgroundGuimarães, H., Rocha, G., & Pissarra, S. (2019). Nasal CPAP complications in preterm infants. Journal of Neonatal Nursing, 25(3), 125-131.
- Background: PubMed 31174382Field T. Pediatric Massage Therapy Research: A Narrative Review. Children (Basel). 2019 Jun 6;6(6):78. doi: 10.3390/children6060078.
- Background: PubMed 18254011De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD002977. doi: 10.1002/14651858.CD002977.pub2.
- Background: PubMed 19686402Coughlin M, Gibbins S, Hoath S. Core measures for developmentally supportive care in neonatal intensive care units: theory, precedence and practice. J Adv Nurs. 2009 Oct;65(10):2239-48. doi: 10.1111/j.1365-2648.2009.05052.x.
- BackgroundCheong, J. L. Y., Spittle, A. J., Burnett, A. C., Anderson, P. J., & Doyle, L. W. (2020). Preterm birth and neurodevelopmental outcomes. Clinics in Perinatology, 47(1), 1-14.
- BackgroundBehnke, J., Lemyre, B., & Laughon, M. (2019). Non-invasive respiratory support in neonates. Current Opinion in Pediatrics, 31(2), 220-226.
- Background: PubMed 8439193Acolet D, Modi N, Giannakoulopoulos X, Bond C, Weg W, Clow A, Glover V. Changes in plasma cortisol and catecholamine concentrations in response to massage in preterm infants. Arch Dis Child. 1993 Jan;68(1 Spec No):29-31. doi: 10.1136/adc.68.1_spec_no.29.
- BackgroundAsadollahi, M., Eskandari, N., & Hasanpour, M. (2016). Effects of developmental care on preterm infant outcomes: A review study. International Journal of Pediatrics, 4(10), 3711-3720.
- Background: PubMed 40723099Arham M, Wroblewska-Seniuk K. Short- and Long-Term Consequences of Late-Preterm and Early-Term Birth. Children (Basel). 2025 Jul 9;12(7):907. doi: 10.3390/children12070907.
Related trials for Neonatal
Active, not recruitingPhase 2
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
DOCK8 Deficiency
Recruiting
Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Meconium Exposure
Neonatal Respiratory Distress Related Conditions, Meconium
RecruitingObservational study
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Charcot Marie Tooth Disease
RecruitingObservational study
Blood Sampling for Research Related to Sickle Cell Disease
Sickle Cell Trait, Sickle Cell Disease
Recruiting
The Effect of Probiotics in Infantile Colic
Infantile Colic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fadime Kısa, BsC contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 1. İntervention group and 2. İntervention group in people with Neonatal and Preterm, run by Tarsus University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Duygu SÖNMEZ DÜZKAYA, PhD (++903246000033 ext. 2200, duygusduzkaya@tarsus.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
NEWBORN INFORMATIONAL FORM (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07773896, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.